,_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg "ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells")
ABT199/venetoclax synergism with thiotepa enhances cytotoxicity of chemo drugs in AML cells
A new research paper was published in Oncotarget's Volume 15 on March 14, 2024, entitled, "ABT199/venetoclax synergism with thiotepa enhances ...
Tag: Acute Myeloid Leukemia
Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant
Bottom line: Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute ...
MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers
The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to ...
Chronic inflammation's influence on TP53 mutations in leukemia evolution explored in new study
In a recent study published in Nature Genetics, researchers performed an allelic-level single-cellular multi-omics evaluation of hematopoietic stem/progenitor cells (HSPCs) ...
Case report and review of a novel chromosomal abnormality in AML patient
A new research paper was published in Genes & Cancer on June 28, 2023, entitled, "A novel t (5; 17) ...
2023 PCRF grant recipients announced for exploring new, safer treatments for pediatric cancers
The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by accelerating research breakthroughs, today announced ...
Break Through Cancer funds AML research at MD Anderson
The University of Texas MD Anderson Cancer Center was awarded more than $5.7 million in grants from Break Through Cancer ...
Mitophagy helps blood cancer cells to evade the killing effects of BH3 mimetic drug
Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often ...
Scientists develop a marker for therapy response in acute myeloid leukemia
With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the ...
Research shows the benefits of screening AML patients in remission for residual disease before bone marrow transplant
Researchers at the National Institutes of Health show the benefits of screening adult patients in remission from acute myeloid leukemia ...
POPULAR NEWS
